Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA–A2

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Nature

• Publication date

  1987-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/325625A0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications.

  1986cited by this paper
• Relating the structure of major transplantation antigens to immune function.

  1986cited by this paper
• Speculations on sequence homologies between the fibronectin cell-attachment site, major histocompatibility antigens, and a putative AIDS virus polypeptide.

  1986cited by this paper
• Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17.

  1986cited by this paper
• Class I genes and molecules: an update.

  1986cited by this paper
• Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes.

  1986cited by this paper
• The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

  1986cited by this paper
• The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.

  1986cited by this paper
• Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.

  1985cited by this paper
• Amino acid sequence specificities of an adhesive recognition signal

  1985cited by this paper
• Exon shuffling in vivo can generate novel HLA class I molecules.

  1985cited by this paper
• Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule

  1985cited by this paper
• HLA Class I Genes: From Structure to Expression, Serology and Function

  1985cited by this paper
• Structural Analysis of the Functional Sites of Class I HLA Antigens

  1985cited by this paper
• Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype.

  1985cited by this paper
• Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level.

  1985cited by this paper
• The complete primary structure of HLA-Bw58.

  1985cited by this paper
• Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

  1984cited by this paper
• Structural analysis of an HLA-B7 antigen variant detected by cytotoxic T lymphocytes.

  1984cited by this paper
• Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant.

  1983cited by this paper
• HLA-A2 mutants immunoselected in vitro. Definition of residues contributing to an HLA-A2-specific serological determinant

  1983cited by this paper
• Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen

  1983cited by this paper
• Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences.

  1983cited by this paper
• The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.

  1983cited by this paper
• Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: evidence for a discrete CTL recognition region.

  1983cited by this paper
• Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1.

  1982cited by this paper
• Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens.

  1982cited by this paper
• The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.

  1980cited by this paper
• Development and characterization of allospecific long-term human cytolytic T-cell lines.

  1980cited by this paper
• Heavy chain of HLA-A and HLA-B antigens is conformationally labile: a possible role for beta 2-microglobulin.

  1979cited by this paper
• MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

  1979cited by this paper
• Assembly and maturation of HLA-A and HLA-B antigens in vivo.

  1979cited by this paper
• Inhibition of killer‐target cell interaction by monoclonal anti‐H‐2 antibodies

  1979cited by this paper
• Human lymphocytes recognise mouse alloantigens

  1975cited by this paper
• Cell‐mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse

  1974cited by this paper
• Progress in Allergy.

  1949cited by this paper

• The Immunology of Transplantation

  2019cites this paper
• Immunobiology of Allograft Human Leukocyte Antigens in the New Microenvironment

  2015influential citation
• Effect of major burns on early and late activating markers of peripheral blood T lymphocytes.

  2012cites this paper
• human allogeneic microvascular endothelium Signal requirements for the generation of CD4+ and CD8+ T-cell responses to

  2011cites this paper
• Subtle Mimicry of HLA by HIV-1 GP120 – A Role for Anti HLA Antibodies?

  2010cites this paper
• Soluble HLA‐I‐mediated secretion of TGF‐β1 by human NK cells and consequent down‐regulation of anti‐tumor cytolytic activity

  2009cites this paper
• HIV induced AIDS and related cancers: chronic immune activation and future therapeutic strategies.

  2008cites this paper
• Chapter 2 – Immunology of Graft Rejection

  2008cites this paper
• Impact of culture conditions on the proliferative lifespan of human T cells in vitro.

  2007cites this paper
• Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.

  2007cites this paper
• RDP 1258 , a New Rationally Designed Immunosuppressive Peptide , Prolongs Allograft Survival in Rats : Analysis of Its Mechanism of Action

  2007cites this paper
• Soluble human major histocompatibility class I antigens: new immunomodulatory functions for old molecules

  2006cites this paper
• Calcium Calmodulin Kinase II , and lck p 56 Mediated : Evidence for the Involvement of HLA Class I Molecules Is Fas Ligand / Fas upon the Engagement of CD 8 by Soluble Apoptosis of Antigen-Specific T Lymphocytes

  2005cites this paper
• Non-expression of HLA-A*0283N.

  2005cites this paper
• Comparison of the structure of HLA-Bw47 to HLA-B13 and its relationship to 21-hydroxylase deficiency

  2004cites this paper
• Analysis of novel residues of class I involved in recognition by alloreactive T cells

  2004cites this paper
• Peripheral blood lymphocytes immunophenotype and serum concentration of soluble HLA class I in burn patients.

  2003cites this paper
• DQ 65–79, A Peptide Derived from HLA Class II, Mimics p21 to Block T Cell Proliferation 1

  2003cites this paper
• I-Aa POLYMORPHIC RESIDUES THAT DETERMINE ALLOREACTIVE T CELL RECOGNITION

  2003cites this paper
• Class II , Mimics p 21 to Block T Cell 79 , A Peptide Derived from HLA − DQ 65

  2003cites this paper
• The mosaic of immunosuppressive drugs.

  2003cites this paper
• HLA Peptide-mediated Strategies for Modulation of Cellular and Humoral Immune Response in Transplantation

  2003cites this paper
• ProliferationClass II, Mimics p21 to Block T Cell 79, A Peptide Derived from HLA - DQ 65

  2003cites this paper
• Pre- and posttransplant immunologic monitoring: why, when, and how?

  2002cites this paper
• Multiple Effects of a Protective Gene that Prevents Graft Rejection

  2002cites this paper
• Heme Oxygenase-1 (HO-1)

  2002cites this paper
• B Expression κ II , Induces I 79 , a Peptide Derived from HLA Class − DQ 65

  2002cites this paper
• Soluble HLA Class I Molecules/CD8 Ligation Trigger Apoptosis of CD8 Cells by Fas/Fas-Ligand Interaction

  2002cites this paper
• DQ 65–79, a Peptide Derived from HLA Class II, Induces IκB Expression1

  2002cites this paper
• Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance.

  2002cites this paper
• In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules:do they play a role in autologous blood transfusion?

  2001cites this paper
• Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.

  2001cites this paper
• Histocompatibility Antigens and Transplant Rejection

  2001cites this paper
• Oxide in Response to Self- and Alloantigens Nitric Oxide Synthase and Generate Nitric Thymic Dendritic Cells Express Inducible

  2000cites this paper
• Blocking T Cell Proliferation Cycle Sensor for an HLA-Derived Peptide Proliferating Cell Nuclear Antigen as the Cell

  2000cites this paper
• Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes.

  2000cites this paper
• Oral feeding of an immunodominant MHC donor‐derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high‐responder rat strain combination

  2000cites this paper
• HLA and Transplantation I: Allorecognition of HLA Molecules in Transplantation

  2000cites this paper
• Expression of heme oxygenase-1 by endothelial cells: a protective response to injury in transplantation

  2000cites this paper
• Proliferating Cell Nuclear Antigen as the Cell Cycle Sensor for an HLA-Derived Peptide Blocking T Cell Proliferation1

  2000cites this paper
• The Immune Response to Alloantigens

  2000cites this paper
• Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction.

  2000cites this paper
• AN IMMUNOSUPPRESSIVE AND ANTI-INFLAMMATORY HLA CLASS I-DERIVED PEPTIDE BINDS VASCULAR CELL ADHESION MOLECULE-11

  2000cites this paper
• Thymic Dendritic Cells Express Inducible Nitric Oxide Synthase and Generate Nitric Oxide in Response to Self- and Alloantigens1

  2000cites this paper
• Soluble HLA Class I and Fas Ligand Molecules in Blood Components and their Role in the Immunomodulatory Effects of Blood Transfusions

  2000cites this paper
• Soluble HLA Class I, HLA Class II, and Fas Ligand in Blood Components: A Possible Key to Explain the Immunomodulatory Effects of Allogeneic Blood Transfusions

  1999cites this paper
• β2‐μ‐free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with β2‐μ‐associated HLA class I heavy chain levels and HLA phenotype

  1999cites this paper
• A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry.

  1999cites this paper
• Prolongation of heart xenograft survival in a hamster-to-rat model after therapy with a rationally designed immunosuppressive peptide.

  1999cites this paper
• Recent advances in immunosuppressants.

  1999cites this paper
• RDP1258, a New Rationally Designed Immunosuppressive Peptide, Prolongs Allograft Survival in Rats: Analysis of Its Mechanism of Action

  1999cites this paper
• Logical approach to transplant patient monitoring.

  1999cites this paper
• HLA-derived peptides as novel immunomodulatory therapeutics.

  1999cites this paper
• Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions.

  1999cites this paper
• Future trends in immunological monitoring of transplant patients.

  1998cites this paper
• Characterization and Biological Significance of Immunosuppressive Peptide D2702.75–84(E → V) Binding Protein

  1998cites this paper
• Induction of tolerance in rodent cardiac allotransplantation using an MHC class I-derived peptide and cyclosporin A.

  1998cites this paper
• Purified truncated recombinant HLA-B7 molecules abrogate cell function in alloreactive cytotoxic T lymphocytes by apoptosis induction.

  1998cites this paper
• Expression of heat shock protein 70 blocks thymic differentiation of T cells in transgenic mice

  1998cites this paper
• Altered Major Histocompatibility Complex Proteins and Peptides for the Induction of Tolerance After Organ Transplantation

  1998cites this paper
• Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin.

  1998cites this paper
• Immunosuppression by D-isomers of HLA class I heavy chain (amino acid 75 to 84)-derived peptides is independent of binding to HSC70.

  1997cites this paper
• Peptide-mediated immunosuppression.

  1997cites this paper
• Treatment with an HLA-peptide and cyclosporine A prolongs rat small bowel allograft survival.

  1997cites this paper
• Recent advances in graft‐versus‐host disease (GVHD) prevention

  1997cites this paper
• Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation.

  1997cites this paper
• Survival of rat small bowel allografts treated with allotrap 07R.

  1997cites this paper
• Synchronous decline of serum-soluble HLA class I antigen and beta-cell function in insulin-dependent diabetes mellitus.

  1997cites this paper
• Biochemical and functional characterization of soluble multivalent MHC L(d)/Fc gamma 1 and L(d)/Fc mu chimeric proteins loaded with specific peptides.

  1997cites this paper
• Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.

  1997cites this paper
• Transplantation Immunology: Peptides in the groove cause histocompatibility

  1996cites this paper
• DISTRIBUTION OF HLA‐G ALTERNATIVE mRNAs INCLUDING SOLUBLE FORMS IN NORMAL LYMPHOCYTES AND IN LYMPHOID CELL‐DERIVED LEUKEMIA

  1996cites this paper
• Why do we reject a graft? Mechanisms of recognition of transplantation antigens

  1996cites this paper
• Peptide specificity of alloreactive CD4 positive T lymphocytes directed against a major histocompatibility complex class I disparity.

  1996cites this paper
• Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes

  1996cites this paper
• The contribution of peptides to T cell allorecognition and allograft rejection.

  1996cites this paper
• The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance.

  1996cites this paper
• Presentation of HLA Class I‐Derived Peptides: Potential Involvement in Allorecognition and HLA‐B27‐Associated Arthritis

  1996cites this paper
• Gene Technology

  1996cites this paper
• Activation requirements of memory cytotoxic T cells

  1996cites this paper
• HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family

  1996cites this paper
• Structure of HLA molecules and immunosuppressive effects of HLA derived peptides.

  1996cites this paper
• Synthetic Peptides Derived from Human MHC Class I Sequences Delay Allograft Rejection in Rodents and Inhibit Cell‐Mediated Cytotoxicity In Vivo and In Vitro

  1996cites this paper
• Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.

  1996cites this paper
• HLA-Derived Peptides as Novel Immunosuppressives

  1995cites this paper
• Donor human leukocyte antigens in the circulation of liver allograft recipients

  1995cites this paper
• Immunosuppressive peptides corresponding to MHC class I sequences.

  1995cites this paper
• Serum HLA class I antigens: markers and modulators of an immune response?

  1995cites this paper
• Evidence that the elevation of soluble MHC class I antigens in the serum precedes the onset of graft-versus-host disease and is correlated with the severity of the disease in rats.

  1995cites this paper
• The induction of tolerance to alloantigens using HLA-based synthetic peptides.

  1994cites this paper
• Dendritic Cells and the Initiation of the Immune Response to Organ Transplants

  1994cites this paper
• Presentation and recognition of major and minor histocompatibility antigens.

  1994cites this paper
• Interaction of papain‐digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL)

  1993cites this paper
• T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection.

  1993cites this paper
• The molecular basis of allorecognition.

  1993cites this paper
• Complement component C1r mediated cleavage of the heavy chain of the major histocompatibility class I antigens.

  1992cites this paper
• Procede de modulation de la reaction de lymphocytes t de mammiferes

  1992cites this paper
• Modulation of restricted class II T cell responses by peptides derived from self class II molecule

  1992cites this paper
• Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection

  1992cites this paper
• Cell‐type‐specific recognition of allogeneic cells by alloreactive cytotoxic T cells: A consequence of peptide‐dependent allorecognition

  1991cites this paper